BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16574685)

  • 1. Ramping up endogenous defences against chronic kidney disease.
    Eddy AA
    Nephrol Dial Transplant; 2006 May; 21(5):1174-7. PubMed ID: 16574685
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents.
    Negri AL
    J Nephrol; 2004; 17(4):496-503. PubMed ID: 15372410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bone morphogenetic proteins (BMPs). Their role in renal fibrosis and renal function.
    Klahr S
    J Nephrol; 2003; 16(2):179-85. PubMed ID: 12768064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [BMP-7 (Bone morphogenetic protein-7): a future treatment for chronic renal failure?].
    Niksic L; Martin PY
    Rev Med Suisse; 2005 Feb; 1(8):568-70, 572-3. PubMed ID: 15794307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balance between bone morphogenetic proteins and their antagonists in kidney injury.
    Yanagita M
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S38-43. PubMed ID: 17976084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP7 signaling in renal development and disease.
    Patel SR; Dressler GR
    Trends Mol Med; 2005 Nov; 11(11):512-8. PubMed ID: 16216558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenic protein-7 and the kidney: current concepts and open questions.
    Zeisberg M
    Nephrol Dial Transplant; 2006 Mar; 21(3):568-73. PubMed ID: 16373388
    [No Abstract]   [Full Text] [Related]  

  • 8. Vascular calcification and uremia: what do we know?
    Cozzolino M; Mazzaferro S; Pugliese F; Brancaccio D
    Am J Nephrol; 2008; 28(2):339-46. PubMed ID: 18046081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of rapamycin in the progression of renal fibrosis.
    Damião MJ; Bertocchi AP; Monteiro RM; Gonçalves GM; Cenedeze MA; Feitoza CQ; Marques GD; Giannocco G; Mazzali M; Teixeira VP; Dos Reis MA; Pacheco-Silva A; Câmara NO
    Transplant Proc; 2007 Mar; 39(2):457-9. PubMed ID: 17362758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of renal disease: is it enough to inhibit the action of angiotensin II?
    Dussaule JC; Chatziantoniou C
    Cell Death Differ; 2007 Jul; 14(7):1343-9. PubMed ID: 17396129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What unique acid-base considerations exist in dialysis patients?
    Oh MS; Uribarri J; Weinstein J; Schreiber M; Kamel KS; Kraut JA; Madias NE; Laski ME
    Semin Dial; 2004; 17(5):351-64. PubMed ID: 15461741
    [No Abstract]   [Full Text] [Related]  

  • 12. Engineering of bone grafts.
    Niklason LE
    Nat Biotechnol; 2000 Sep; 18(9):929-30. PubMed ID: 10973207
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone morphogenetic proteins and growth differentiation factors as drug targets in cardiovascular and metabolic disease.
    Tobin JF; Celeste AJ
    Drug Discov Today; 2006 May; 11(9-10):405-11. PubMed ID: 16635802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of bone morphogenetic protein-7 in human scalp skin and hair follicles.
    Adly MA; Assaf HA; Hussein MR
    Br J Dermatol; 2006 Mar; 154(3):551-4. PubMed ID: 16445791
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcification and the usual suspect phosphate: still guilty but there are other guys behind the scenes.
    Ketteler M; Floege J
    Nephrol Dial Transplant; 2006 Jan; 21(1):33-5. PubMed ID: 16287912
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone morphogenetic protein 7 (BMP7): a critical role in kidney development and a putative modulator of kidney injury.
    Archdeacon P; Detwiler RK
    Adv Chronic Kidney Dis; 2008 Jul; 15(3):314-20. PubMed ID: 18565482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing reversible self-association of therapeutic proteins by sedimentation velocity in the analytical ultracentrifuge.
    Perez-Ramirez B; Steckert JJ
    Methods Mol Biol; 2005; 308():301-18. PubMed ID: 16082044
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone morphogenetic proteins in clinical applications.
    Gautschi OP; Frey SP; Zellweger R
    ANZ J Surg; 2007 Aug; 77(8):626-31. PubMed ID: 17635273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic proteins and the induction of bone formation: from laboratory to patients.
    Ripamonti U; Heliotis M; Ferretti C
    Oral Maxillofac Surg Clin North Am; 2007 Nov; 19(4):575-89, vii. PubMed ID: 18088907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein.
    Xiao YT; Xiang LX; Shao JZ
    Biochem Biophys Res Commun; 2007 Oct; 362(3):550-3. PubMed ID: 17719560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.